Winrevair

Showing 2 posts of 2 posts found.

NICE recommends sotatercept for pulmonary arterial hypertension

May 20, 2026
NICE, Winrevair, pulmonary arterial hypertension, sotatercept

The National Institute for Health and Care Excellence (NICE) has recommended Winrevair (sotatercept) as a treatment option for adults with …

FDA approves Merck’s Winrevair for PAH treatment

March 27, 2024
Medical Communications Cardiology, FDA, Merck, Winrevair, pulmonary arterial hypertension

Merck, known as MSD outside of the US and Canada, has announced that the US Food and Drug Administration (FDA) …

The Gateway to Local Adoption Series

Latest content